aTYR PHARMA INC Operating Leases, Rent Expense
aTYR PHARMA INC (ATYR) reported Operating Leases, Rent Expense of $1.00 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-24.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2021-03-24
- aTYR PHARMA INC operating leases, rent expense for the quarter ending 2018-12-31 was $200.00K, a 0.00% change year-over-year.
- aTYR PHARMA INC operating leases, rent expense for the quarter ending 2018-09-30 was $300.00K, a 0.00% change year-over-year.
- aTYR PHARMA INC operating leases, rent expense for the quarter ending 2018-06-30 was $300.00K, a 0.00% change year-over-year.
- aTYR PHARMA INC operating leases, rent expense for the quarter ending 2018-03-31 was $300.00K, a 50.00% increase year-over-year.
- aTYR PHARMA INC operating leases, rent expense for fiscal 2020 was $1.00M, a 0.00% change from fiscal 2019.
- aTYR PHARMA INC operating leases, rent expense for fiscal 2019 was $1.00M, a 0.00% change from fiscal 2018.
- aTYR PHARMA INC operating leases, rent expense for fiscal 2018 was $1.00M, a 11.11% increase from fiscal 2017.
- aTYR PHARMA INC operating leases, rent expense for fiscal 2017 was $900.00K, a 80.00% increase from fiscal 2016.
| Period end | Operating Leases, Rent Expense 3 month | Operating Leases, Rent Expense 6 month | Operating Leases, Rent Expense 9 month | Operating Leases, Rent Expense 12 month |
|---|---|---|---|---|
| 2020-12-31 | $1.00M 10-K · filed 2021-03-24 | |||
| 2019-12-31 | $1.00M 10-K · filed 2021-03-24 | |||
| 2018-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | $500.00K derived: sum of 2 quarters · filed 2021-03-24 | $800.00K derived: sum of 3 quarters · filed 2021-03-24 | $1.00M 10-K · filed 2021-03-24 |
| 2018-09-30 | $300.00K 10-Q · filed 2018-11-14 | $600.00K derived: sum of 2 quarters · filed 2018-11-14 | $800.00K 10-Q · filed 2018-11-14 | $1.10M derived: sum of 4 quarters · filed 2020-03-26 |
| 2018-06-30 | $300.00K 10-Q · filed 2018-08-14 | $600.00K 10-Q · filed 2018-08-14 | $800.00K derived: sum of 3 quarters · filed 2020-03-26 | $1.10M derived: sum of 4 quarters · filed 2020-03-26 |
| 2018-03-31 | $300.00K 10-Q · filed 2018-05-15 | $500.00K derived: sum of 2 quarters · filed 2020-03-26 | $800.00K derived: sum of 3 quarters · filed 2020-03-26 | $1.10M derived: sum of 4 quarters · filed 2020-03-26 |
| 2017-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $500.00K derived: sum of 2 quarters · filed 2020-03-26 | $800.00K derived: sum of 3 quarters · filed 2020-03-26 | $900.00K 10-K · filed 2020-03-26 |
| 2017-09-30 | $300.00K 10-Q · filed 2018-11-14 | $600.00K derived: sum of 2 quarters · filed 2018-11-14 | $700.00K 10-Q · filed 2018-11-14 | $1.00M derived: sum of 4 quarters · filed 2019-03-26 |
| 2017-06-30 | $300.00K 10-Q · filed 2018-08-14 | $400.00K 10-Q · filed 2018-08-14 | $700.00K derived: sum of 3 quarters · filed 2019-03-26 | $800.00K derived: sum of 4 quarters · filed 2019-03-26 |
| 2017-03-31 | $200.00K 10-Q · filed 2018-05-15 | $400.00K derived: sum of 2 quarters · filed 2019-03-26 | $500.00K derived: sum of 3 quarters · filed 2019-03-26 | $600.00K derived: sum of 4 quarters · filed 2019-03-26 |
| 2016-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | $300.00K derived: sum of 2 quarters · filed 2019-03-26 | $400.00K derived: sum of 3 quarters · filed 2019-03-26 | $500.00K 10-K · filed 2019-03-26 |
| 2016-09-30 | $100.00K 10-Q · filed 2017-11-14 | $200.00K derived: sum of 2 quarters · filed 2017-11-14 | $300.00K 10-Q · filed 2017-11-14 | $400.00K derived: sum of 4 quarters · filed 2018-03-20 |
| 2016-06-30 | $100.00K 10-Q · filed 2017-08-14 | $200.00K 10-Q · filed 2017-08-14 | $300.00K derived: sum of 3 quarters · filed 2018-03-20 | $400.00K derived: sum of 4 quarters · filed 2018-03-20 |
| 2016-03-31 | $100.00K 10-Q · filed 2017-05-11 | $200.00K derived: sum of 2 quarters · filed 2018-03-20 | $300.00K derived: sum of 3 quarters · filed 2018-03-20 | $400.00K derived: sum of 4 quarters · filed 2018-03-20 |
| 2015-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20 | $200.00K derived: sum of 2 quarters · filed 2018-03-20 | $300.00K derived: sum of 3 quarters · filed 2018-03-20 | $400.00K 10-K · filed 2018-03-20 |
| 2015-09-30 | $100.00K 10-Q · filed 2016-11-14 | $200.00K derived: sum of 2 quarters · filed 2016-11-14 | $300.00K 10-Q · filed 2016-11-14 | $400.00K derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-06-30 | $100.00K 10-Q · filed 2016-08-10 | $200.00K 10-Q · filed 2016-08-10 | $300.00K derived: sum of 3 quarters · filed 2017-03-16 | $400.00K derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-03-31 | $100.00K 10-Q · filed 2016-05-11 | $200.00K derived: sum of 2 quarters · filed 2017-03-16 | $300.00K derived: sum of 3 quarters · filed 2017-03-16 | $400.00K derived: sum of 4 quarters · filed 2017-03-16 |
| 2014-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $200.00K derived: sum of 2 quarters · filed 2017-03-16 | $300.00K derived: sum of 3 quarters · filed 2017-03-16 | $200.00K 10-K · filed 2017-03-16 |
| 2014-09-30 | $100.00K 10-Q · filed 2015-11-10 | $200.00K derived: sum of 2 quarters · filed 2015-11-10 | $100.00K 10-Q · filed 2015-11-10 | |
| 2014-06-30 | $100.00K 10-Q · filed 2015-08-12 | $100.00K 10-Q · filed 2015-08-12 | ||
| 2014-03-31 | $100.00K 10-Q · filed 2015-06-18 | |||
| 2013-12-31 | $200.00K 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B |